Herd immunity ‘might now be impossible’. Here’s how we could learn to live with Covid

The US has vaccinated more than half its adults with one dose. But rates are slipping

Vaccinators Joan Love and Mary Hanafin administering Covid-19 vaccinations at the   Aviva Stadium, Co Dublin. File photograph: Alan Betson

Vaccinators Joan Love and Mary Hanafin administering Covid-19 vaccinations at the Aviva Stadium, Co Dublin. File photograph: Alan Betson

 

Early in the pandemic, when vaccines for coronavirus were still just a glimmer on the horizon, the term “herd immunity” came to signify the endgame: the point when enough people would be protected from the virus so we could be rid of the pathogen and reclaim our lives.

The United States is among the countries that have inoculated more than half of their adults with at least one dose of a vaccine. But its daily vaccination rates are slipping, and there is widespread consensus among scientists and public-health experts that the herd-immunity threshold is not attainable – at least not in the foreseeable future, and perhaps not ever.

Instead, they are coming to the conclusion that rather than making a long-promised exit, the virus will most likely become a manageable threat that will continue to circulate for years to come, still causing hospitalisations and deaths but in much smaller numbers.

To say the herd-immunity goal will not be attained adds another ‘Why bother?’ to the list of reasons that vaccine sceptics use to avoid being inoculated

How much smaller is uncertain and depends in part on how much of the United States, and the world, becomes vaccinated and how coronavirus evolves. It is already clear, however, that the virus is changing too quickly, new variants are spreading too easily and vaccination is proceeding too slowly for herd immunity to be within reach anytime soon.

Continued immunisations, especially for people at highest risk because of age, exposure or health status, will be crucial to limiting the severity of outbreaks, if not their frequency, experts believe.

“The virus is unlikely to go away,” says Rustom Antia, an evolutionary biologist at Emory University, in Atlanta. “But we want to do all we can to check that it’s likely to become a mild infection.”

The shift in outlook presents a new challenge for public-health authorities in the US and globally. The drive for herd immunity – by the summer, some experts once thought possible – captured the imagination of large segments of the public. To say the goal will not be attained adds another “Why bother?” to the list of reasons that vaccine sceptics use to avoid being inoculated.

Yet vaccinations remain the key to transforming the virus into a controllable threat, experts say. Dr Anthony Fauci, President Biden’s top adviser on Covid-19, acknowledges the shift in experts’ thinking.

“People were getting confused and thinking you’re never going to get the infections down until you reach this mystical level of herd immunity, whatever that number is,” he says.

“That’s why we stopped using herd immunity in the classic sense,” he adds. “I’m saying: Forget that for a second. You vaccinate enough people, the infections are going to go down.”

Once coronavirus began to spread across the globe, in early 2020, it became increasingly clear that the only way out of the pandemic would be for so many people to gain immunity – whether through natural infection or vaccination – that the virus would run out of people to infect. The concept of reaching herd immunity became the implicit goal in many countries, including the US.

Early on, the target herd-immunity threshold was estimated to be about 60-70 per cent of the population. Most experts, including Fauci, expected that the US would be able to reach it once vaccines were available.

But as vaccines were developed and distribution ramped up through the winter and into the spring, estimates of the threshold began to rise. That is because the initial calculations were based on the contagiousness of the original version of the virus. The predominant variant now circulating in the US, Ireland and elsewhere, called B117 and first identified in Britain, is about 60 per cent more transmissible.

As a result, experts now calculate the herd-immunity threshold to be at least 80 per cent. If even more contagious variants develop, or if scientists find that immunised people can still transmit the virus, the calculation will have to be revised upwards again.

The connectivity between countries, particularly as travel restrictions ease, emphasises the urgency of protecting not just Americans but everyone in the world

Polls show that about 30 per cent of the US population is still reluctant to be vaccinated. That number is expected to improve but probably not enough. “It is theoretically possible that we could get to about 90 per cent vaccination coverage, but not super likely,” says Marc Lipsitch, a public-health researcher at the Harvard TH Chan school of public health.

Although resistance to the vaccines is a main reason the US is unlikely to reach herd immunity, it is not the only one. Herd immunity is often described as a national target. But that is a hazy concept in a country as large as the United States.

“Disease transmission is local,” Lipsitch notes. “If the coverage is 95 per cent in the United States as a whole, but 70 per cent in some small town, the virus doesn’t care,” he explains. “It will make its way around the small town.”

How insulated a particular region is from the virus depends on a dizzying array of factors.

Herd immunity can fluctuate with “population crowding, human behaviour, sanitation and all sorts of other things”, says Dr David M Morens, a virus expert and senior adviser to Fauci. “The herd immunity for a wealthy neighbourhood might be x. Then you go into a crowded neighbourhood one block away and it’s 10x.”

Given the degree of movement among regions, a small virus wave in a region with a low vaccination level can easily spill over into an area where a majority of the population is protected.

People on the National Mall in Washington DC, US. Polls show that about 30 per cent of the US population is still reluctant to be vaccinated. File photograph: Amr Alfiky/New York Times
Polls show that about 30 per cent of Americans are reluctant to be vaccinated. Photograph: Amr Alfiky/New York Times

At the same time, the connectivity between countries, particularly as travel restrictions ease, emphasises the urgency of protecting everyone in the world, says Natalie E Dean, a biostatistician at the University of Florida in Gainesville. Any variants that arise in the world will eventually reach countries such as the US, she notes.

Many parts of the world lag far behind on vaccinations. Fewer than 2 per cent of the people in India have been fully vaccinated, for example, and fewer than 1 per cent in South Africa.

“We will not achieve herd immunity as a country or a state or even as a city until we have enough immunity in the population as a whole,” says Lauren Ancel Meyers, the director of the Covid-19 modelling consortium at the University of Texas at Austin.

What the future may hold

If the herd-immunity threshold is not attainable, what matters most is the rate of hospitalisations and deaths after pandemic restrictions are relaxed, experts believe.

By focusing on vaccinating the most vulnerable, the US has already brought those numbers down sharply. If the vaccination levels of that group continue to rise, the expectation is that over time the coronavirus may become seasonal, like the flu, and affect mostly the young and healthy.

“What we want to do at the very least is get to a point where we have just really sporadic little flare-ups,” says Carl Bergstrom, an evolutionary biologist at the University of Washington in Seattle. “That would be a very sensible target in this country, where we have an excellent vaccine and the ability to deliver it.”

Over the long term – a generation or two – the goal is to transition the new coronavirus to become more like its cousins that cause common colds. That would mean the first infection is early in childhood, and subsequent infections are mild because of partial protection, even if immunity wanes.

Emphasising the benefits of vaccination to people’s lives, such as seeing a family member or sending their children to school, might be more motivating than the nebulous idea of herd immunity

Some unknown proportion of people with mild cases may go on to experience debilitating symptoms for weeks or months – the syndrome known as long Covid – but they are unlikely to overwhelm the healthcare system.

“The vast majority of the mortality and of the stress on the healthcare system comes from people with a few particular conditions, and especially people who are over 60,” Lipsitch says. “If we can protect those people against severe illness and death, then we will have turned Covid from a society disrupter to a regular infectious disease.”

If communities maintain vigilant testing and tracking, it may be possible to bring the number of new cases so low that officials can identify any new introduction of the virus and stifle a potential outbreak, says Bary Pradelski, an economist at the National Centre for Scientific Research in France. He and his colleagues described this strategy in a paper just published in the scientific journal the Lancet.

“Eradication is, I think, impossible at this stage,” Pradelski says. “But you want local elimination.”

Vaccination is still the key

The endpoint has changed, but the most pressing challenge remains the same: persuading as many people as possible to get the shot.

Reaching a high level of immunity in the population “is not like winning a race”, Lipsitch says. “You have to then feed it. You have to keep vaccinating to stay above that threshold.”

Scepticism about the vaccines among many Americans and lack of access in some groups – homeless populations, migrant workers or some communities of colour – make it a challenge to achieve that goal. Vaccine mandates would only make that stance worse, some experts believe.

A better approach would be for a trusted figure to address the root cause of the hesitancy – fear, mistrust, misconceptions, ease of access or a desire for more information, says Mary Politi, an expert in health decision-making and health communication at Washington University in St Louis.

People often need to see others in their social circle embracing something before they are willing to try it, Politi says. Emphasising the benefits of vaccination to their lives, such as seeing a family member or sending their children to school, might be more motivating than the nebulous idea of herd immunity.

“That would resonate with people more than this somewhat elusive concept that experts are still trying to figure out,” she adds.

Over time, if not enough people are protected, highly contagious variants may develop that can break through vaccine protection, land people in the hospital and put them at risk of death

Although children spread the virus less efficiently than adults do, the experts all agree that vaccinating children would also be important for keeping the number of Covid cases low. In the long term, the public-health system will also need to account for babies, and for children and adults who age into a group with higher risk.

Unnerving scenarios remain on the path to this long-term vision.

Over time, if not enough people are protected, highly contagious variants may develop that can break through vaccine protection, land people in the hospital and put them at risk of death.

“That’s the nightmare scenario,” says Jeffrey Shaman, a public-health researcher at Columbia University, in New York.

How frequent and severe those breakthrough infections are may determine whether the US can keep hospitalisations and deaths low or if the country will find itself in a “mad scramble” every couple of years, he says.

“I think we’re going to be looking over our shoulders – or at least public-health officials and infectious-disease epidemiologists are going to be looking over their shoulders going: ‘All right, the variants out there – what are they doing? What are they capable of?’” he says. “Maybe the general public can go back to not worrying about it so much, but we will have to.” – New York Times

The Irish Times Logo
Commenting on The Irish Times has changed. To comment you must now be an Irish Times subscriber.
SUBSCRIBE
GO BACK
Error Image
The account details entered are not currently associated with an Irish Times subscription. Please subscribe to sign in to comment.
Comment Sign In

Forgot password?
The Irish Times Logo
Thank you
You should receive instructions for resetting your password. When you have reset your password, you can Sign In.
The Irish Times Logo
Please choose a screen name. This name will appear beside any comments you post. Your screen name should follow the standards set out in our community standards.
Screen Name Selection

Hello

Please choose a screen name. This name will appear beside any comments you post. Your screen name should follow the standards set out in our community standards.

The Irish Times Logo
Commenting on The Irish Times has changed. To comment you must now be an Irish Times subscriber.
SUBSCRIBE
Forgot Password
Please enter your email address so we can send you a link to reset your password.

Sign In

Your Comments
We reserve the right to remove any content at any time from this Community, including without limitation if it violates the Community Standards. We ask that you report content that you in good faith believe violates the above rules by clicking the Flag link next to the offending comment or by filling out this form. New comments are only accepted for 3 days from the date of publication.